Subject(s)
Lymphatic Diseases/pathology , Lymphatic System/pathology , Skin Diseases, Vascular/pathology , Vascular Malformations/pathology , Adolescent , Dermoscopy/methods , Female , Humans , Lymphatic Diseases/complications , Lymphatic System/abnormalities , Skin Diseases, Vascular/diagnostic imaging , Vascular Malformations/etiologyABSTRACT
Paget disease of the breast is an uncommon tumor of the nipple-areola complex that usually presents as an erythematous and erosive lesion. We report the case of a 61-year-old man that presented with a three-year history of an erythematous lesion of the right areola, first treated with topical corticosteroids without benefit. He was then referred to our dermatology department and the clinical suspicion of Paget disease was considered. The diagnosis was later confirmed by biopsy. This case report highlights the importance of clinical recognition of this entity along with other diseases that mimic these skin changes in order to allow earlier diagnosis and proper follow-up.
Subject(s)
Breast Neoplasms, Male/diagnosis , Breast Neoplasms, Male/pathology , Paget's Disease, Mammary/diagnosis , Paget's Disease, Mammary/pathology , Biopsy , Carrier Proteins/metabolism , Glycoproteins/metabolism , Humans , Keratin-7/metabolism , Male , Membrane Transport Proteins , Middle Aged , NipplesSubject(s)
Bacterial Toxins/analysis , Exotoxins/analysis , Furunculosis/diagnosis , Leukocidins/analysis , Staphylococcal Infections/diagnosis , Staphylococcus aureus/chemistry , Angola/ethnology , Biopsy , Furunculosis/ethnology , Furunculosis/microbiology , Humans , Male , Middle Aged , Portugal/epidemiology , Recurrence , Skin/microbiology , Skin/pathology , Staphylococcal Infections/ethnology , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification , TravelABSTRACT
We describe a patient with a generalized bullous form of Fixed Drug Eruption (FDE) induced by bromhexine, a commonly used drug for respiratory symptoms. This is a rare association and generalized bullous FDE is also very rare. We emphasize the importance of patch tests in identifying the culprit drug.
Subject(s)
Bromhexine/adverse effects , Drug Eruptions/etiology , Expectorants/adverse effects , Hypersensitivity, Delayed/chemically induced , Skin Diseases, Vesiculobullous/chemically induced , Drug Eruptions/pathology , Humans , Hypersensitivity, Delayed/pathology , Male , Middle Aged , Skin/pathology , Skin Diseases, Vesiculobullous/pathologyABSTRACT
Due to undesirable hazardous interactions with biological systems, we evaluated the effect of silver nanoparticles (AgNPs) intake on oxidative stress and inflammation. Rats received for 81 days a standard diet (Controls) or a standard diet plus 500 mg/d/kg BW AgNPs. We assayed plasma lipids, and oxidative stress was assessed by measuring liver and heart superoxide anion production (O2°â») and liver malondialdehyde levels (MDA). Antioxidant status was appraised using plasma paraoxonase activity (PON), plasma antioxidant capacity (PAC) and liver superoxide dismutase activity (SOD). Liver inflammatory cytokines TNFα and IL-6 levels and plasma alanine aminotransferase (ALT) were assayed. Compared with Controls, AgNPs raised cholesterolemia (9.5%), LDL-cholesterol (30%), and lowered triglycerides (41%). They also increased liver (30%) and cardiac (41%) O2°â» production, reduced PON activity (15%) and raised liver TNFα (9%) and IL-6 (â¼12%). Plasma ALT activity rose (12%) after treatment with AgNPs. However, PAC and liver MDA and SOD activity were unchanged. These features indicate that exposure to 500 mg/d/kg BW of AgNPs results in liver damage by a dysregulation of lipid metabolism, highlighting liver and heart as the most sensitive organs to the deleterious effects. Our findings also demonstrate for the first time the oxidative and inflammatory effects of dietary AgNPs.
